Abstract on the Mectizan® Donation Program (MDP), which was launched in 1987 by Merck & Co., Inc., Kenilworth, N.J., U.S.A.* Thylefors, Annals of Tropical Medicine and Parasitology, 2008 Sep; 102 Suppl 1:39-44. 2008.
*Merck & Co., Inc., Kenilworth, N.J., U.S.A., is known as MSD outside of the United States and Canada.
Warning: count(): Parameter must be an array or an object that implements Countable in /home/ntdngone/public_html/wp-content/themes/mdp-theme/single-news-resources.php on line 94
The World Health Organization (WHO) is developing a toolkit to help programs implement MMDP services. The toolkit incorporates relevant resources developed by WHO and partner institutions, and its objectives are as follows:
provide tools and templates for implementation of key activities to strengthen delivery by the health system of the recommended minimum package of care for LF patients
make information and tools accessible to national LF programs and health professionals around the world
identify and resolve gaps in resources
Components focus on the following areas:
Planning, including patient estimation
Capacity Building to Deliver MMDP Services
Documentation of MMDP services
Article on the importance of cross-border issues in onchocerciasis elimination programmes. Bush, Sodahlon, Downs and Mackenzie, International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages i54–i59.
Article on the use of alternative (or complementary) treatment strategies (ATSs) to accelerate the elimination of onchocerciasis. Boussinesq et al., International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages i40–i48.
A review summarizing the progress made in identifying diagnostics that meet the specialized requirements needed to verify onchocerciasis elimination, as well as a discussion of why these tests were selected and a summary of the needs that still exist to complete the arsenal of diagnostic tools that will be useful as the goal of elimination is achieved.